Table 2.
Summary of differences in common comorbidities associated with PsA and RA29 88 90 182–185
| Comorbidity | PsA | RA |
| Thyroid disorders | – | ✓ |
| Infections | – | ✓ |
| Osteoporosis | – | ✓ |
| Lymphoma | – | ✓ |
| Haematopoietic malignancies | – | ✓ |
| Skin cancer | – | ✓ |
| Cataracts/glaucoma | – | ✓ |
| Uveitis | SpA with axial involvement and/or HLA-B27 positivity | – |
| IBD | SpA with axial involvement | – |
| Psoriasis | ✓ | – |
| Overweight/obese | ✓ | – |
| Diabetes mellitus | ✓ | – |
| Metabolic syndrome | ✓ | – |
| Hypertriglyceridaemia | ✓ | – |
| Anxiety and depression | ✓ | – |
| NAFLD | ✓ | – |
| Hypertension | – | – |
| Hyperlipidaemia | – | – |
HLA, human leucocyte antigen; IBD, inflammatory bowel disease; NAFLD, non-alcoholic fatty liver disease; PsA, psoriatic arthritis; RA, rheumatoid arthritis; SpA, spondyloarthritis.